Financhill
Back

Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
28.84
Seasonality Move:
22.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Apellis Pharmaceuticals Price Quote

$28.84
+0.77 (+2.72%)
(Updated: November 6, 2024 at 10:35 AM ET)

Apellis Pharmaceuticals Key Stats

Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Day range:
$24.34 - $28.33
52-week range:
$24.34 - $73.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.45
P/B ratio:
12.93%

Volume:
9.9M
Avg. volume:
3.3M
1-year change:
-40.05%
Market cap:
$3.4B
Revenue:
$396.6M
EPS:
$-2.74

How Much Does Apellis Pharmaceuticals Make?

Is Apellis Pharmaceuticals Growing As A Company?

Apellis Pharmaceuticals Stock Price Performance

What Is Apellis Pharmaceuticals 52-Week High & Low?

Apellis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Apellis Pharmaceuticals?

Is Apellis Pharmaceuticals Cash Flow Positive?

  • What Is APLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$408.3M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $152.5M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$426K

Apellis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    APLS return on invested capital is -78.06%
  • What Is Apellis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -39.08%
  • What Is APLS Return On Equity?
    ROE is a measure of profitability and is -127.72%

Apellis Pharmaceuticals Earnings Date & Stock Price

Apellis Pharmaceuticals Competitors

Apellis Pharmaceuticals Dividend Yield

Apellis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -88.46%
Revenue: 110.26% -1.5%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 59.58
Upside from Last Price: 112.21%

Major Shareholders

  • How many APLS shares are owned by institutional investors?
    192.2M APLS shares are owned by institutional investors
  • How many APLS shares are owned by insiders?
    3.8M APLS shares are owned by insiders